ABSTRACT
Pharmacologic therapies and neuromodulation have been used for the management of detrusor overactivity, bladder dysfunction with poor compliance, and non-compliant small capacity bladders with or without overactivity due to infectious, inflammatory, neurogenic, congenital, iatrogenic, and idiopathic disorders. When more conservative therapies are ineffective, augmentation cystoplasty is indicated.
